Faster skin repair may prolong inflammation by bonding microbial peptides to tissue proteins
In previously sensitized people, tissue transglutaminase TG2 may link microbial peptides to tissue proteins during repair, sustaining inflammation after microbial clearance. No detectable conjugates with sufficiently sensitive analysis, or equal activity of linked and free forms, would refute this proposal.
Stage of verification
- Hypothesis published2026-09-25
- Indirect evidenceAssessed at 4 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Biological function
The biological function description is being prepared
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.

Metabolism and energy
Peptide conjugation
Formation of covalent bonds joining peptides to other peptides or proteins
Where this hypothesis actsRepairing skin in previously sensitized people exposed to repeated wetting and microinjury
Hypotheses on this target 1
Inhibition1
Activation
Function preservation
Supplementation
Feedback restoration
Direct measurement

What is proposed
Inhibition
Prevent covalent conjugation of microbial peptides with tissue proteins
With whatNot stated in the record
HowEliminate microbial substrates available for conjugation before accelerating repair; the substrate removal method is not stated
Possible result
Possible prevention of late inflammation and stabilization of SPV_5 while preserving SPV_1 and SPV_6
From the recordПроверяемая последовательность восстановления: устранение доступных для конъюгации микробных субстратов, ускорение репарации, завершение воспаления.

Rhythm or programme
Skin barrier repair
The process that restores the skin barrier after damage
Where this hypothesis actsPreviously sensitized skin undergoing repeated wetting and microinjury
Hypotheses on this target 1
Inhibition
Activation1
Function preservation
Feedback restoration
Rhythm restoration
Direct measurement

What is proposed
Activation
Accelerate repair after eliminating microbial substrates available for conjugation
With whatNot stated in the record
HowSequence repair after substrate elimination and before inflammation resolution; the method for accelerating repair is not stated
Possible result
Possible barrier recovery without prolonging inflammation through peptide conjugation
From the recordустранение доступных для конъюгации микробных субстратов, ускорение репарации, завершение воспаления
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
Skin that closes quickly could still carry material that keeps inflammation going. The unexpected move is that microbial fragments might become chemically attached to the skin's own proteins during repair, remaining after microorganisms and free fragments have been cleared. This is a proposal generated by the pipeline, not a measured result.
- The immune system already recognizes relevant microbial material in the proposed susceptible group.
- Faster repair is proposed to let TG2 attach microbial peptides to the skin's own proteins.
- Microbial material changes from free fragments that can be removed to chemically attached fragments proposed to persist after clearance.
- The attached material is proposed to sustain recognition by T cells, immune cells that respond to particular molecular targets, and thereby prolong inflammation.
- Repeated wetting and small injuries are proposed to restart formation of the attached material.
- Removing attachable microbial material before accelerating repair is proposed to interrupt this sequence and allow inflammation to end.
Repairs could glue scraps of an old warning notice into a wall: clearing the loose scraps would leave a warning that still gets noticed.
Where the picture breaks: Immune cells do not read attached fragments directly like a notice. The material must be made available for immune recognition, and the proposal has not established that these particular attachments produce that response in skin.
- Master questionstep 01 of 04
The goal is a treatment that restores middle-aged people's skin function to the level of younger people's skin.
Rests on: The stated goal makes functional recovery, rather than appearance alone, the target.
Stated in the chain - Goal pillarstep 02 of 04
Skin's protective responses must remain compatible when several stresses occur together.
Rests on: The goal requires better skin function, but does not identify compatibility between protective responses as a limiting factor.
AssumptionThe chain assumes that interference between protective responses contributes to the functional difference between middle-aged and younger skin.
- Gap questionstep 03 of 04
Faster restoration of the skin barrier, the outer protection that limits passage into and out of skin, might retain microbial material underneath and prolong inflammation during repeated wetting. The question is whether a particular order of repair and inflammation ending prevents that conflict.
Rests on: The preceding stage identifies compatibility under simultaneous stresses, but supplies no specific connection between faster closure, retained microbial material and prolonged inflammation.
LeapThe missing connection is evidence or an explicit prior rationale that faster barrier closure retains inflammatory microbial material during repeated wetting. The supplied sources do not establish that connection.
- Hypothesisstep 04 of 04
In previously sensitized people, whose immune systems already recognize the relevant material, faster repair is proposed to attach microbial peptides, short protein fragments, to tissue proteins. Tissue transglutaminase 2, abbreviated TG2, is the proposed enzyme, a protein that speeds a chemical reaction. The resulting covalent conjugates, molecules joined by strong chemical bonds, are proposed to sustain inflammation directed at the recognized material after microbial clearance; wetting and small injuries would renew their formation.
Rests on: The preceding question supplies the proposed conflict between closure and persistence of microbial stimuli. The hypothesis supplies chemical attachment as a candidate explanation, with removal of attachable microbial material before accelerated repair as its proposed sequence.
Stated in the chain
What is carried, and what is not. The supplied sources support background pieces: Biochimica et biophysica acta (2013), available here only as an abstract, links TG2 to repair-related cell attachment and movement in mouse corneas and cultured human corneal cells, not microbial attachment in skin; Frontiers in bioscience (2006) describes chemical protein bonds in skin and healing, not the proposed microbial–human attachments. Cell death & disease (2017) reports less ultraviolet-induced inflammation in mice lacking TG2, not persistence driven by attached microbial fragments; none of the supplied sources establishes the proposed sequence end to end.
Where the reasoning is carried by something unstated · 2
- Goal pillar. The chain assumes that interference between protective responses contributes to the functional difference between middle-aged and younger skin.
- Gap question. The missing connection is evidence or an explicit prior rationale that faster barrier closure retains inflammatory microbial material during repeated wetting. The supplied sources do not establish that connection. Establish the missing link before relying on this step.
How a result here could mislead · 3
- Less inflammation after interfering with TG2 could reflect altered healing or another inflammatory route rather than prevention of microbial attachment. Equal external mechanical load would also not by itself establish equal cell injury, the cause proposed by one rival. What closes it: Measure attachment formation alongside actual barrier permeability, meaning how readily substances pass through it, healing and cell injury. The specified comparisons require matched permeability, mechanical load and free microbial material; the design also needs evidence that reduced inflammation follows reduced attachment rather than a change in these neighbouring causes.
- Inflammation restored by an isolated preparation of attached material could be credited to the chemical bonds when carried-over microbial debris caused it. Absence of live bacteria does not exclude the rival explanation involving continued breakdown of bacterial cell-wall remnants inside immune cells. What closes it: Establish the preparation's composition and control for unbound material and bacterial cell-wall remnants. Compare attached material with equivalent amounts of its unbound components, as the hypothesis specifies, so that attachment rather than a different mixture accounts for the difference.
- A negative immune response could be read as disproving the mechanism when the tissue lacks the required immune cells or the donor was never sensitized. An isolated skin sample cannot reproduce the acquisition of new sensitization. What closes it: The immune test requires autologous cells, meaning cells from the same donor: both cells that present material for immune recognition and responding lymphocytes, the immune-cell group that includes T cells. Establish prior recognition and the cells' ability to respond before interpreting a negative result; detecting the chemical attachments alone does not establish their inflammatory effect.
What would make this wrong. The proposal specifies two decisive failures: no microbial–human chemical attachments despite an analysis sensitive enough to detect them, or equal immune activity from attached material and an equivalent mixture of unbound components. Either would break a required link, provided the immune test contains responsive cells from an appropriately sensitized donor. No numerical detection threshold is supplied.
What it would change. If the hypothesis held, restoring skin function could depend on clearing material that can become attached before accelerating repair, because rapid closure alone could leave an inflammatory stimulus behind. Work toward younger-like function would then need to assess the order of clearance, repair and inflammation ending in the susceptible group. Even a positive result in human skin samples maintained outside the body would not establish a treatment that restores middle-aged skin to younger people's function, or its effects during repeated wetting in living people. The supplied outcome codes SPV_1, SPV_5 and SPV_6 are undefined, so their proposed preservation or stabilization cannot be translated into specific functional benefits.
Sources read · 7
Molecular mechanism of transglutaminase-2 in corneal epithelial migration and adhesion. · Biochimica et biophysica acta · 2013
“TG-2 dependent β-3 integrin activation, serine-phosphorylation of paxillin, and Rac and CDC42 activation may thus play a key functional role in enhancing corneal epithelial cell adhesion and migration during wound healing.”
Does not settle: Источник описывает заживление роговицы у мышей и культуру эпителиальных клеток роговицы человека. Он не устанавливает образование TG2-конъюгатов микробных пептидов с белками кожи, сенсибилизацию людей, сохранение воспаления после удаления микроорганизмов, эффект повторного намокания или микроповреждений и последовательность SPV.
Tissue transglutaminase: from biological glue to cell survival cues. · Frontiers in bioscience : a journal and virtual library · 2006
“The accumulation of isopeptide bonds can be observed in skin, hair and during blood clotting and wound healing.”
Does not settle: Источник не устанавливает образование TG2-конъюгатов микробных пептидов с белками кожи, предварительную сенсибилизацию людей, поддержание антигенспецифического воспаления, эффект повторного намокания или микроповреждений, а также последствия предотвращения таких конъюгатов для SPV_1, SPV_5 и SPV_6.
MTA1 coregulation of transglutaminase 2 expression and function during inflammatory response. · The Journal of biological chemistry · 2011
“Here we investigated the role of MTA1 in the regulation of TG2 expression in bacterial lipopolysaccharide (LPS)-stimulated mammalian cells.”
Does not settle: Источник не устанавливает образование TG2 ковалентных конъюгатов микробных пептидов с белками кожи, их роль в сохранении воспаления, влияние репарации или повторного намокания и микроповреждений, а также последствия предотвращения таких конъюгатов для SPV_1, SPV_5 или SPV_6.
Immune cell dynamics and mechanisms of epithelial injury in celiac disease. · Frontiers in immunology · 2026
“Gluten peptides entering the lamina propria are deamidated by TG2 and presented by HLA-DQ2/DQ8–positive antigen-presenting cells, activating naïve T cells in the context of epithelial IL-15 and DC-derived IFN-α.”
Does not settle: Источник описывает слизистую кишечника при целиакии и деамидирование глютеновых пептидов TG2. Он не устанавливает ковалентное связывание микробных пептидов с белками кожи при репарации, роль предварительной сенсибилизации, сохранение воспаления после удаления микроорганизмов, влияние намокания или микроповреждений либо последствия предотвращения таких конъюгатов для SPV_5, SPV_1 и SPV_6.
Critical Role for Transglutaminase 2 in Scleroderma Skin Fibrosis and in the Development of Dermal Sclerosis in a Mouse Model of Scleroderma. · Arthritis & rheumatology (Hoboken, N.J.) · 2025
“Within the extracellular environment, TGM2 can become active leading to the extensive crosslinking between many distinct ECM proteins (eg, collagens and fibronectin). Therefore, TGM2 is considered to play a key role in the regulation and homeostasis of the ECM in wound healing and other critical biologic processes such as cell adhesion, motility, and survival.”
Does not settle: Источник не устанавливает образование TG2-конъюгатов микробных пептидов с белками кожи, предварительную сенсибилизацию людей, сохранение антигенспецифического воспаления после элиминации микроорганизмов, эффект намокания или микроповреждений, проверяемую последовательность восстановления либо влияние предотвращения конъюгатов на SPV_5, SPV_1 и SPV_6.
Transglutaminase 2 mediates UV-induced skin inflammation by enhancing inflammatory cytokine production. · Cell death & disease · 2017
“Our results showed that TG2-deficient mice exhibited reduced inflammatory responses to UV irradiation, including reduced erythema, edema, dilation of blood vessels, inflammatory cell infiltration, and levels of inflammatory cytokines.”
Does not settle: Источник изучает вызванное ультрафиолетом воспаление у мышей и в культурах кератиноцитов. Он не устанавливает ковалентное связывание микробных пептидов с белками ткани, предварительную сенсибилизацию людей, репарацию ран, повторное намокание или микроповреждения, сохранение воспаления после удаления микроорганизмов либо эффекты на SPV_1, SPV_5 и SPV_6.
Keratinocyte transglutaminase 2 promotes CCR6+ γδT-cell recruitment by upregulating CCL20 in psoriatic inflammation. · Cell death & disease · 2020
“In summary, we demonstrated that keratinocyte-derived TG2 mediates IL-6, CXCL8, and CCL20 expression by activating NF-κB and amplifies the interaction between keratinocytes and immune cells in psoriatic skin lesions by recruiting neutrophils and IL-17-producing γδT-cells.”
Does not settle: This mouse psoriasis-model study does not establish covalent bonding of microbial peptides to tissue proteins during skin repair, persistence after microbial clearance, sensitization in people, effects of re-wetting or microinjury, or the proposed repair sequence and SPV outcomes.
The gap this hypothesis explains
Two established results predict opposite outcomes, and both cannot be right.
Can faster skin sealing trap microbial triggers and prolong inflammation, and what repair order prevents this during repeated wetting?
Original wording · exactly as the pipeline generated it
Может ли ускоренное закрытие барьера продлевать воспаление, сохраняя под ним микробные стимулы, и какая последовательность восстановления барьера и прекращения воспаления предотвращает это при повторном намокании?
What this question is asking
The question concerns whether making damaged skin close faster can leave inflammation-causing material underneath the repaired surface. It asks whether accelerating restoration of the skin barrier, the outer protective layer, reduces inflammation by limiting further entry or prolongs it by retaining microbes or their products. It also asks how the order of barrier restoration and inflammation ending affects that outcome when skin repeatedly becomes wet. The comparison is between different orders of these processes, tracking microbial amounts, passage through the barrier, inflammation, and healing over hours or days. The question assumes that barrier protection limits entry while microbial products can continue to stimulate inflammation, but the supplied material does not establish the specific supporting mechanism labeled RL-2.
- Skin barrier
- The protective outer part of skin that limits passage of water and other material. Its function can recover by degrees; a visibly closed wound does not by itself establish how effectively this protection works.
- Barrier restoration or skin sealing
- Recovery of the skin's protective surface. The question uses closure as part of this process, but restoration of protective function and visible closure are distinct measurements.
- Wound closure
- Reduction or disappearance of an open wound area. Several supplied sources report faster closure, without establishing that all microbial triggers have disappeared.
- Microbes and microbial triggers
- Microbes are microscopic organisms, including bacteria. Microbial triggers are organisms or material from them that can stimulate inflammation, so their presence is not measured completely by counting living bacteria.
- Microbial metabolites
- Substances produced or changed by microbes through their chemical activity. The proposed question treats some of these substances as possible continuing inflammatory triggers; the supplied excerpts do not identify which ones.
- Microbial or bacterial burden
- The amount of microbes or bacteria present. A decrease in bacterial burden does not by itself establish removal of every microbial product.
- Inflammation and its resolution
- Inflammation is the body's tissue response to damage or microbial threats. Resolution means that this response subsides; it need not occur at the same time as surface closure.
- Barrier permeability
- How readily a measured substance passes through the skin barrier. The input asks for permeability to return within limits but supplies neither those limits nor the substance to be measured.
- Repeated wetting
- Skin becoming wet on multiple occasions. The input does not specify the liquid, duration, frequency, or drying intervals, and seawater exposure alone does not establish this repeated pattern.
- Bacterial colonization and biofilm
- Colonization means bacteria establish themselves at a site. A biofilm is an attached community of microbes within material they produce; S5 describes these communities as aggravating inflammation.
- Oxidative stress
- A condition in which chemically reactive substances exceed the tissue's ability to control them and can cause damage. S1 and S2 describe treatments that reduce these substances or their harmful effects alongside repair-related changes.
- Skin-surface cell maturation
- The process by which cells acquire the features needed for their roles in the outer skin. S2 reports signs of this process, which are not equivalent to demonstrating complete barrier function.
- Bacteria-derived particles
- Small membrane-enclosed packages released by bacteria. S1 describes sustained delivery of such particles to support tissue repair after an earlier treatment release.
- Atopic dermatitis
- An inflammatory skin disorder commonly associated with eczema. It is the disease setting in S3, rather than evidence about all repeatedly wetted skin.
- Plasma-activated water
- Water treated using an energized gas, changing its chemical properties. S7 evaluates it as a wound-rinsing treatment in seawater-exposed burns in rats.
- Ceramides
- A class of fatty molecules involved in the skin's protective outer layer. S9 discusses their benefits, but does not establish a sequence for barrier recovery and inflammation ending.
- Chronic wound and moisture-related skin damage
- A chronic wound is one that remains unhealed over a prolonged period. Excessive wound fluid can soften and damage nearby skin, the process discussed in S10.
- RL-2
- An unexplained label in the pipeline's gap description. The supplied material does not identify its underlying source, mechanism, or measurement, so no more specific definition is established.
Barrier protection labeled RL-2 predicts reduced penetration, while microbial metabolites labeled RL-2 allow continuing stimulation, creating a possible conflict between accelerated barrier closure and inflammation ending.
The assumption links the skin's protective surface with substances made by microbes: repairing the surface would reduce incoming material, but substances already present could keep the tissue inflamed. The supplied input does not explain what RL-2 identifies. If this connection held, the order of removing inflammatory triggers and restoring the surface could help explain why faster closure sometimes helps and sometimes fails to end inflammation.
S4 describes how a damaged barrier may allow microbes to reach deeper skin layers, and S5 describes how bacteria and biofilms can aggravate inflammation. These support background links, but neither establishes retention of microbial products beneath an accelerated repair or identifies the proposed RL-2 mechanism. None of the supplied excerpts establishes that mechanism under repeated wetting; this absence does not show that the claim is false.S4S5
The same question asked without the part nothing read establishes:
- During repeated wetting, does faster restoration of the skin barrier change retained microbial material and the duration of inflammation?
- During repeated wetting, how does the order of barrier restoration and inflammation ending affect microbial amounts, barrier permeability, and healing?
- Faster sealing prolongs inflammation If faster sealing retains material that continues to stimulate inflammation, surface closure would occur before the underlying inflammatory cause disappears. Closure alone would then overstate recovery, and the order in which microbial stimulation subsides and the barrier closes would affect the outcome.
- Faster sealing shortens inflammation If preventing further microbial entry outweighs any effect of retained material, faster restoration would reduce the continuing supply of inflammatory triggers. Under those conditions, earlier barrier recovery could contribute to earlier resolution of inflammation.
- The effect depends on conditions If reduced entry and retained stimulation contribute differently across wounds or wetting conditions, faster sealing could have different effects on inflammation. A sequence associated with recovery in one setting would then not establish the sequence that prevents prolonged inflammation in another.
If a damaged barrier allows microbes to enter skin, restoring it could reduce further entry and thereby reduce one source of inflammation; S4 describes the possible entry step. If microbes or their products remain active beneath the restored surface, however, reduced entry would not necessarily remove the existing inflammatory stimulus; this is the question's proposed mechanism, not a demonstrated finding. S5 describes bacteria and their attached communities as aggravating inflammation, while S10 reports that excessive wound fluid can damage surrounding skin and delay healing. Confusing visible wound closure with removal of inflammatory triggers could therefore misrepresent recovery, whereas assuming closure necessarily traps those triggers could misrepresent treatments that improve closure and bacterial control together.
Барьерная защита RL-2 предсказывает уменьшение проникновения; микробные метаболиты RL-2 допускают продолжающуюся стимуляцию; последовательность вмешательств не проверена.
За часы или сутки микробная нагрузка, проницаемость и воспаление должны последовательно вернуться в заданные пределы без нарушения заживления.
Не установлено, при каких условиях ускоренное закрытие сокращает воспаление, а при каких сохраняет его причину и требует иной последовательности лечения.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
У предварительно сенсибилизированной части людей ускоренное восстановление кожи химически закрепляет микробные пептиды в собственных белках ткани. Предполагаемый катализатор, тканевая трансглутаминаза TG2, образует ковалентные конъюгаты во время репарации. Эти соединения поддерживают антигенспецифическое воспаление после уничтожения микроорганизмов и удаления свободных микробных продуктов. Повторное намокание и микроповреждения возобновляют образование конъюгатов. Проверяемая последовательность восстановления: устранение доступных для конъюгации микробных субстратов, ускорение репарации, завершение воспаления. Предотвращение образования конъюгатов должно стабилизировать SPV_5 при сохранении SPV_1 и SPV_6.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковых проницаемости, механической нагрузке и количестве свободных микробных продуктов ускоренная репарация увеличит содержание ковалентных соединений микробных и человеческих пептидов и продлит ответ аутологичных Т-клеток. Предотвращение конъюгации устранит позднее воспаление; добавление выделенных конъюгатов вернёт его без живых бактерий. Эквивалентная смесь несвязанных компонентов даст меньший ответ. Отсутствие конъюгатов при достаточной чувствительности анализа либо одинаковая активность связанной и свободной форм опровергнет гипотезу.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies observable intervention effects, a qualitative comparison, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Химический этап можно проверить в человеческих эксплантатах с мечеными неинфекционными микробными пептидами и масс-спектрометрией поперечных сшивок. Для иммунного этапа нужны аутологичные антигенпредставляющие клетки и лимфоциты. Самостоятельный эксплантат не воспроизводит формирование новой сенсибилизации. Любое вмешательство в TG2 требует отдельного контроля заживления и сопоставления фактической проницаемости.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковых проницаемости, механической нагрузке и количестве свободных микробных продуктов ускоренная репарация увеличит содержание ковалентных соединений микробных и человеческих пептидов и продлит ответ аутологичных Т-клеток. Предотвращение конъюгации устранит позднее воспаление; добавление выделенных конъюгатов вернёт его без живых бактерий. Эквивалентная смесь несвязанных компонентов даст меньший ответ. Отсутствие конъюгатов при достаточной чувствительности анализа либо одинаковая активность связанной и свободной форм опровергнет гипотезу.
- Rival 01 of 02What would separate them
Rapid skin barrier closure may prolong inflammation through dissipative mechanical damage predicts: В очищенной от микробных компонентов ткани быстрый протокол восстановления вызовет больше необратимой механической работы, повреждения клеток и более длительный воспалительный ответ, чем плавный протокол с тем же конечным состоянием барьера. При одинаковой длительности протокол, приближающийся к постоянной термодинамической скорости, уменьшит эти показатели относительно протокола с резкими изменениями. Если измеренная диссипация различается, а повреждение и воспаление не меняются, предполагаемая причинная связь опровергнута.
- What would separate them
Lysosomal digestion of bacterial cell walls may prolong skin inflammation predicts: При одинаковой массе поглощённого пептидогликана и отсутствии жизнеспособных бактерий поздний выход зрелого интерлейкина-1β будет зависеть от скорости лизосомного расщепления частиц. Обратимое торможение соответствующего катализа после микробного очищения уменьшит этот выход, а возобновление катализа восстановит его без повторного повреждения барьера. Эффект сохранится в системе без Т-клеток. Отсутствие зависимости при подтверждённом изменении расщепления опровергнет гипотезу.
Why this is not the mainstream account
The engine is asked to say what its hypothesis would overturn and what would surprise a specialist. This is its answer.
В исследовании Lindstad и соавторов комплексы TG2 с глютеном обеспечивали эффективное взаимодействие антигенспецифических B- и T-клеток; многовалентность усиливала действие при сопоставимом содержании пептида. Это экспериментальная опора для роли химической формы антигена, но прямых данных о микробных конъюгатах в заживающей коже работа не содержит. [Первичное исследование](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0259082).
Иммунология заживления кожи, учебная глава «Репарация тканей и разрешение воспаления». Подтверждение потребует включить образование новых антигенных комплексов самой репарацией как самостоятельную причину хронического воспаления после микробного очищения.
Бесклеточная фракция ковалентных конъюгатов, выделенная из успешно восстановленной кожи, воспроизводит позднее воспаление в аутологичной системе после удаления свободных микробных стимулов. Предотвращение образования этих соединений позволяет ускорять закрытие без воспалительного штрафа.
В выполненном целевом поиске не найдено обзора, утверждающего именно этот механизм при ускоренном восстановлении возрастной кожи и повторном намокании. Родственный механизм антигенных комплексов известен при целиакии. Отсутствие публикаций во всей литературе не доказано; статус HERETICAL предварительный.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.